ArticlePLoS neglected tropical diseases2015
Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics.
Erratum issuedAbstract read
In one paragraph
Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Defining a malaria diagnostic pathway from innovation to adoption: Stakeholder perspectives on data and evidence gaps.PLOS global public health · 2024Article
- Nanotechnology, equity and global health.Nature nanotechnology · 2021Article
- Long-term dry storage of enzyme-based reagents for isothermal nucleic acid amplification in a porous matrix for use in point-of-care diagnostic devices.The Analyst · 2020Article
- Point-Of-Care or Point-Of-Need Diagnostic Tests: Time to Change Outbreak Investigation and Pathogen Detection.Tropical medicine and infectious disease · 2020Review
- Passive micropumping in microfluidics for point-of-care testing.Biomicrofluidics · 2020Review
- Biosensors for Personal Mobile Health: A System Architecture Perspective.Advanced materials technologies · 2020Article
- Recent Advances in the Development of Biosensors for Malaria Diagnosis.Sensors (Basel, Switzerland) · 2020Review
- Article
- NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment.Chemical science · 2019Article
- Amoxicillin Quality and Selling Practices in Urban Pharmacies and Drug Stores of Blantyre, Malawi.The American journal of tropical medicine and hygiene · 2018Article
- The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays.Nano letters · 2017Article
- An Open Software Platform for the Automated Design of Paper-Based Microfluidic Devices.Scientific reports · 2017Article
- Challenges and Opportunities of Centrifugal Microfluidics for Extreme Point-of-Care Testing.Micromachines · 2016Review
- Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.Expert review of molecular diagnostics · 2016Review
- Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform.BMJ global health · 2016Article
- National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: Advancing Precision Medicine.IEEE journal of translational engineering in health and medicine · 2016Article
- Article
- Correction: Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics.PLoS neglected tropical diseases · 2015Article
- Improving health-care delivery in low-resource settings with nanotechnology: Challenges in multiple dimensions.NanobiomedicineArticle
- Salivary point-of-care technology.European journal of dentistryArticle
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Ratmir DerdaDepartment of Chemistry and Alberta Glycomics Centre, University of Alberta, Edmonton, Alberta, Canada.
Jesse GitakaDepartment of Clinical Medicine, Mount Kenya University, Thika, Kenya.
Catherine M KlapperichDepartment of Biomedical Engineering and Center for Future Technologies in Cancer Care, Boston University, Boston, Massachusetts, United States of America.
Charles R MaceDiagnostics For All, Cambridge, Massachusetts, Unites States of America; Department of Chemistry, Tufts University, Medford, Massachusetts, United States of America.
Ashok A KumarSchool of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, United States of America.
Marya LiebermanDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, United States of America.
Jacqueline C LinnesDepartment of Biomedical Engineering and Center for Future Technologies in Cancer Care, Boston University, Boston, Massachusetts, United States of America.
Joerg JoresInternational Livestock Research Institute, Nairobi, Kenya.
Johnson NasimoloDepartment of Veterinary Anatomy and Physiology, University of Nairobi, Nairobi, Kenya.
Joseph Ndung'uFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Evans TarachaInstitute of Primate Research, National Museums of Kenya, Nairobi, Kenya.
Abigail WeaverDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, United States of America.
Douglas B WeibelDepartments of Biochemistry, Biomedical Engineering, and Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Thomas M KariukiInstitute of Primate Research, National Museums of Kenya, Nairobi, Kenya.
Paul YagerDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Funding
Center for Innovation in Point of Care Technologies for the Future of Cancer CareU54EB015403 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KLAPPERICH, CATHERINE M. · 2012 to 2016
$8.9MA high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimensionR01AI096184 · NIAID · UNIVERSITY OF WASHINGTON · PI YAGER, PAUL · 2011 to 2015
$5.2MRapid molecular diagnostic for chlamydia and gonorrhea at the point-of-careR01AI113927 · NIAID · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KLAPPERICH, CATHERINE M. · 2015 to 2018
$1.4MNIAID NIH HHS R01 AI096184NIAID NIH HHS R01 AI113927NIBIB NIH HHS U54 EB015403
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.